{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:42:47Z","timestamp":1786945367419,"version":"build-2736575974"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["153631KYSB20190020"],"award-info":[{"award-number":["153631KYSB20190020"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["ZDBS-ZRKJZ-TLC005"],"award-info":[{"award-number":["ZDBS-ZRKJZ-TLC005"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["TM202101L003"],"award-info":[{"award-number":["TM202101L003"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005153","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["82025032"],"award-info":[{"award-number":["82025032"]}],"id":[{"id":"10.13039\/501100005153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFE0201700"],"award-info":[{"award-number":["2020YFE0201700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014219","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jconrel.2022.11.010","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T18:40:22Z","timestamp":1668192022000},"page":"813-832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Ligand-modified nanocarriers for oral drug delivery: Challenges, rational design, and applications"],"prefix":"10.1016","volume":"352","author":[{"given":"Yaqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.11.010_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104685","article-title":"Oral administration of protein nanoparticles: an emerging route to disease treatment","volume":"158","author":"Sadeghi","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0010","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cclet.2020.02.035","article-title":"The application of biomacromolecules to improve oral absorption by enhanced intestinal permeability: a mini-review","volume":"31","author":"Sun","year":"2020","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0015","article-title":"Oral delivery of biologics for precision medicine","volume":"32","author":"Duran-Lobato","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jconrel.2020.04.006","article-title":"Overcoming the intestinal barrier: a look into targeting approaches for improved oral drug delivery systems","volume":"322","author":"Xu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2020.11.010","article-title":"A quantitative view on multivalent nanomedicine targeting","volume":"169","author":"Woythe","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11070298","article-title":"Delivery of nanoparticles across the intestinal epithelium via the transferrin transport pathway","volume":"11","author":"Yong","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0035","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1021\/acsnano.8b07231","article-title":"Transferrin Functionization elevates transcytosis of nanogranules across epithelium by triggering polarity-associated transport flow and positive cellular feedback loop","volume":"13","author":"Yang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120209","article-title":"Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment","volume":"255","author":"Xu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2020.08.005","article-title":"Engineered albumin-functionalized nanoparticles for improved FcRn binding enhance oral delivery of insulin","volume":"327","author":"Azevedo","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1208\/s12249-019-1297-z","article-title":"Folate-functionalized thiomeric nanoparticles for enhanced docetaxel cytotoxicity and improved oral bioavailability","volume":"20","author":"Sajjad","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202104139","article-title":"Engineering nano- and microparticles as oral delivery vehicles to promote intestinal lymphatic drug transport","author":"Miao","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2018.07.022","article-title":"Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system","volume":"286","author":"Lee","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0065","article-title":"Nanocarriers based oral lymphatic drug targeting: strategic bioavailability enhancement approaches","volume":"64","author":"Pandya","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202100701","article-title":"A noninvasive gut-to-brain oral drug delivery system for treating brain tumors","volume":"33","author":"Miao","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00524","article-title":"Advances in oral drug delivery for regional targeting in the gastrointestinal tract-influence of physiological, pathophysiological and pharmaceutical factors","volume":"11","author":"Hua","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jphp.12852","article-title":"Oral insulin delivery: existing barriers and current counter-strategies","volume":"70","author":"Gedawy","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0085","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41586-021-03225-8","article-title":"Inceptor counteracts insulin signalling in beta-cells to control glycaemia","volume":"590","author":"Ansarullah","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0090","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.molmed.2020.12.001","article-title":"Avoiding a sticky situation: bypassing the mucus barrier for improved local drug delivery","volume":"27","author":"Zierden","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0095","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","article-title":"Mucus barrier, mucins and gut microbiota: the expected slimy partners?","volume":"69","author":"Paone","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002192","article-title":"Modulation of gastrointestinal mucus properties with ionic liquids for drug delivery","volume":"10","author":"Peng","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910224","article-title":"Gut microbiota and dietary factors as modulators of the mucus layer in inflammatory bowel disease","volume":"22","author":"Fernandez-Tome","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0110","article-title":"Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome","author":"Yonghyun","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.09.023","article-title":"The biology of mucus: composition, synthesis and organization","volume":"124","author":"Bansil","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0125","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1080\/10717544.2018.1501119","article-title":"The challenges of oral drug delivery via nanocarriers","volume":"25","author":"Reinholz","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molliq.2019.03.016","article-title":"Biopolymer nanoparticle surface chemistry dictates the nature and extent of protein hard corona","volume":"282","author":"Basu","year":"2019","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0135","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1021\/acsnano.8b03500","article-title":"Evolution of nanoparticle protein corona across the blood\u2013brain barrier","volume":"12","author":"Cox","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.addr.2017.11.002","article-title":"The role of mucus as an invisible cloak to transepithelial drug delivery by nanoparticles","volume":"124","author":"Garc\u00eda-D\u00edaz","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0145","article-title":"Protein corona formed in the gastrointestinal tract and its impacts on oral delivery of nanoparticles","author":"Zhang","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2018.10.011","article-title":"The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system","volume":"552","author":"Xiao","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0155","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/acs.biomac.9b00175","article-title":"Digestive enzyme corona formed in the gastrointestinal tract and its impact on epithelial cell uptake of nanoparticles","volume":"20","author":"Peng","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0160","doi-asserted-by":"crossref","first-page":"21682","DOI":"10.1021\/acsami.5b07631","article-title":"Protein adsorption from biofluids on silica nanoparticles: corona analysis as a function of particle diameter and porosity","volume":"7","author":"Clemments","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0165","first-page":"2273","article-title":"The fate of calcium carbonate nanoparticles administered by oral route: absorption and their interaction with biological matrices","volume":"10","author":"Lee","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0170","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1021\/acsnano.8b04315","article-title":"Oral nanoparticles exhibit specific high-efficiency intestinal uptake and lymphatic transport","volume":"12","author":"Kim","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0175","doi-asserted-by":"crossref","first-page":"11443","DOI":"10.1021\/acsami.7b19153","article-title":"Intestinal mucin induces more endocytosis but less transcytosis of nanoparticles across enterocytes by triggering nanoclustering and strengthening the retrograde pathway","volume":"10","author":"Yang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0180","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.drudis.2016.04.007","article-title":"Intracellular transport of nanocarriers across the intestinal epithelium","volume":"21","author":"Fan","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0185","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jconrel.2016.06.016","article-title":"Nanoparticles for oral delivery: design, evaluation and state-of-the-art","volume":"240","author":"Date","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijbiomac.2019.02.094","article-title":"Breaking the barricade of oral chemotherapy through polysaccharide nanocarrier","volume":"130","author":"Dey","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0195","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.7150\/thno.61747","article-title":"Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0200","article-title":"Engineering nano- and microparticles as oral delivery vehicles to promote intestinal lymphatic drug transport","author":"Yang-Bao","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100064","article-title":"Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration","volume":"8","author":"Nguyen","year":"2022","journal-title":"OpenNano"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0210","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1039\/C9NR03025E","article-title":"Biological fate of ingested lipid-based nanoparticles: current understanding and future directions","volume":"11","author":"Wang","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0215","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1039\/D1BM00020A","article-title":"Angiopep-2-functionalized nanoparticles enhance transport of protein drugs across intestinal epithelia by self-regulation of targeted receptors","volume":"9","author":"Liu","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0220","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12951-021-01100-2","article-title":"Nanomedicine for increasing the oral bioavailability of cancer treatments","volume":"19","author":"Parodi","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0225","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.cclet.2021.01.001","article-title":"STING-activating drug delivery systems: design strategies and biomedical applications","volume":"32","author":"Li","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2020.07.034","article-title":"Bile acid transporter-mediated oral drug delivery","volume":"327","author":"Deng","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0235","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.apsb.2021.07.024","article-title":"The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201907170","article-title":"Biomaterial approaches for understanding and overcoming immunological barriers to effective oral vaccinations","volume":"30","author":"Frizzell","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0245","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1021\/acsnano.0c08596","article-title":"Caveolae-mediated endocytosis drives robust siRNA delivery of polymeric nanoparticles to macrophages","volume":"15","author":"Song","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105861","article-title":"Potential therapies and diagnosis based on Golgi-targeted nano drug delivery systems","volume":"175","author":"Zhang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101356","article-title":"Exocytosis blockade of endoplasmic reticulum-targeted nanoparticle enhances immunotherapy","volume":"42","author":"Chen","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0260","doi-asserted-by":"crossref","first-page":"34039","DOI":"10.1021\/acsami.8b13707","article-title":"Multifunctional nanoparticles enable efficient Oral delivery of biomacromolecules via improving payload stability and regulating the transcytosis pathway","volume":"10","author":"Zheng","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0265","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.2147\/IJN.S257269","article-title":"The influence of nanoparticle properties on oral bioavailability of drugs","volume":"15","author":"Wang","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092961","article-title":"Bile acids transporters of enterohepatic circulation for targeted drug delivery","volume":"27","author":"Durnik","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2019.04.012","article-title":"Exocytosis - a putative road-block in nanoparticle and nanocomplex mediated gene delivery","volume":"303","author":"Dahiya","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113887","article-title":"Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases","volume":"176","author":"Zu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0285","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.addr.2019.07.010","article-title":"Nanocarrier-based systems for targeted and site specific therapeutic delivery","volume":"144","author":"Majumder","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0290","doi-asserted-by":"crossref","first-page":"2819154","DOI":"10.1155\/2018\/2819154","article-title":"Regulation of intestinal epithelial cells properties and functions by amino acids","volume":"2018","author":"Kong","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0295","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2018.02.021","article-title":"Exploiting or overcoming the dome trap for enhanced oral immunization and drug delivery","volume":"275","author":"Qi","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0300","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/gastro\/goz028","article-title":"C-type lectin receptor-mediated immune recognition and response of the microbiota in the gut","volume":"7","author":"Li","year":"2019","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201800462","article-title":"Engineered multifunctional albumin-decorated porous silicon nanoparticles for FcRn translocation of insulin","volume":"14","author":"Martins","year":"2018","journal-title":"SMALL"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0310","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40824-018-0129-7","article-title":"Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus","volume":"22","author":"Cha","year":"2018","journal-title":"Biomater Res"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0315","doi-asserted-by":"crossref","first-page":"38925","DOI":"10.1021\/acsami.0c09814","article-title":"Oral GLP1 gene delivery by an antibody-guided nanomaterial to treat type 2 diabetes mellitus","volume":"12","author":"Hasan","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0320","doi-asserted-by":"crossref","first-page":"44354","DOI":"10.1021\/acsami.8b20821","article-title":"Microfluidic nanoassembly of bioengineered chitosan-modified FcRn-targeted porous silicon nanoparticles @ Hypromellose acetate succinate for oral delivery of antidiabetic peptides","volume":"10","author":"Martins","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0325","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41598-018-19170-y","article-title":"Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice","volume":"8","author":"Shi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0330","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.apsb.2020.11.003","article-title":"Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: opportunities and emerging strategies","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0335","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1039\/C8FO00097B","article-title":"Chitosan binding onto the epigallocatechin-loaded ferritin nanocage enhances its transport across Caco-2 cells","volume":"9","author":"Yang","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0340","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.nano.2017.05.003","article-title":"Mucosal transfer of wheat germ agglutinin modified lipid\u2013polymer hybrid nanoparticles for oral delivery of oridonin","volume":"13","author":"Liu","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0345","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00125-018-4593-3","article-title":"Targeted delivery of antigen to intestinal dendritic cells induces oral tolerance and prevents autoimmune diabetes in NOD mice","volume":"61","author":"Chen","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0350","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biomaterials.2018.01.046","article-title":"Ultrasmall mesoporous organosilica nanoparticles: morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery","volume":"161","author":"Yu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0355","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ymthe.2019.01.003","article-title":"Oral gavage of ginger nanoparticle-derived lipid vectors carrying Dmt1 siRNA blunts Iron loading in murine hereditary hemochromatosis","volume":"27","author":"Wang","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0360","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biomaterials.2019.01.019","article-title":"Hierarchically targetable polysaccharide-coated solid lipid nanoparticles as an oral chemo\/thermotherapy delivery system for local treatment of colon cancer","volume":"197","author":"Shen","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0365","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2217\/nnm-2017-0372","article-title":"Targeted folate-conjugated pluronic P85\/poly(lactide-co-glycolide) polymersome for the oral delivery of insulin","volume":"13","author":"Xie","year":"2018","journal-title":"Nanomedicine (London, England)"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117873","article-title":"Design of biotin decorated enterocyte targeting muco-inert nanocomplexes for enhanced oral insulin delivery","volume":"261","author":"Cui","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0375","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.2147\/IJN.S218944","article-title":"Investigation of vitamin B(12)-modified amphiphilic sodium alginate derivatives for enhancing the oral delivery efficacy of peptide drugs","volume":"14","author":"Long","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0380","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1021\/nn506060q","article-title":"The \u201csweet\u201d side of the protein corona: effects of glycosylation on nanoparticle\u2013cell interactions","volume":"9","author":"Wan","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2019.102075","article-title":"Functional lipid polymeric nanoparticles for oral drug delivery: rapid mucus penetration and improved cell entry and cellular transport","volume":"21","author":"Liu","year":"2019","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0390","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.apsb.2017.11.007","article-title":"Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin","volume":"8","author":"He","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116527","article-title":"Doxorubicin delivered by redox-responsive Hyaluronic Acid\u2013Ibuprofen prodrug micelles for treatment of metastatic breast cancer","volume":"245","author":"Chai","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0400","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1021\/acs.molpharmaceut.6b00871","article-title":"A mechanistic study on nanoparticle-mediated glucagon-like Peptide-1 (GLP-1) secretion from Enteroendocrine L cells","volume":"13","author":"Beloqui","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0405","first-page":"158","article-title":"Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability","volume":"15","author":"Wang","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2021.11.045","article-title":"Dual-modified nanoparticles overcome sequential absorption barriers for oral insulin delivery","volume":"342","author":"Xi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0415","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2018.12.028","article-title":"Long-term oral administration of Exendin-4 to control type 2 diabetes in a rat model","volume":"294","author":"Suzuki","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0420","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1021\/acs.molpharmaceut.8b00713","article-title":"Transport mechanisms of butyrate modified nanoparticles: insight into \u201ceasy entry, hard transcytosis\u201d of active targeting system in oral administration","volume":"15","author":"Wu","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030146","article-title":"Folate and Borneol modified bifunctional nanoparticles for enhanced oral absorption","volume":"10","author":"Yang","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0430","article-title":"The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery","author":"Li","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0435","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejpb.2018.05.022","article-title":"Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport","volume":"129","author":"Gourdon","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0440","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.cclet.2021.08.113","article-title":"A \u201ccluster bomb\u201d oral drug delivery system to sequentially overcome the multiple absorption barriers","volume":"33","author":"Song","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0445","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/21691401.2017.1417864","article-title":"Ascorbate-conjugated nanoparticles for promoted oral delivery of therapeutic drugs via sodium-dependent vitamin C transporter 1 (SVCT1)","volume":"46","author":"Luo","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0450","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrm.2015.25","article-title":"Understanding transport by the major facilitator superfamily (MFS): structures pave the way","volume":"17","author":"Quistgaard","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0455","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.actbio.2016.02.041","article-title":"Multifunctional properties of organic-inorganic hybrid nanocomposites based on chitosan derivatives and layered double hydroxides for ocular drug delivery","volume":"36","author":"Xu","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0460","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1529\/biophysj.106.101295","article-title":"Ion transport across transmembrane pores","volume":"92","author":"Leontiadou","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0465","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.apsb.2018.10.005","article-title":"Emerging transporter-targeted nanoparticulate drug delivery systems","volume":"9","author":"Su","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0470","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2016.10.031","article-title":"Transporter occluded-state conformation-induced endocytosis: amino acid transporter ATB(0,+)-mediated tumor targeting of liposomes for docetaxel delivery for hepatocarcinoma therapy","volume":"243","author":"Luo","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0475","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biomaterials.2017.09.022","article-title":"Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex","volume":"147","author":"Park","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0480","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.10.022","article-title":"Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery","volume":"151","author":"Fan","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0490","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.addr.2012.09.041","article-title":"Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances","volume":"65","author":"Xu","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0495","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/S0168-8278(18)30460-4","article-title":"Internalization of canalicular transporters in estradiol 17 beta-D-glucuronide-induced cholestasis involves shift from \u201craft\u201d to \u201cnon-raft\u201d membrane domains and clathrin-mediated endocytosis","volume":"68","author":"Miszczuk","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0500","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jat.3769","article-title":"Gender difference in hepatic toxicity of titanium dioxide nanoparticles after subchronic oral exposure in Sprague-Dawley rats","volume":"39","author":"Chen","year":"2019","journal-title":"J. Appl. Toxicol."},{"issue":"96","key":"10.1016\/j.jconrel.2022.11.010_bb0505","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/jnci\/djh305","article-title":"Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs","volume":"I","author":"Luciani","year":"2004","journal-title":"Jnci-J Natl Cancer"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00124","article-title":"The emerging role of voltage-gated sodium channels in tumor biology","volume":"9","author":"Mao","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0515","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00334","article-title":"Multiple roles of toll-like receptor 4 in colorectal cancer","volume":"5","author":"Yesudhas","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0520","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3164\/jcbn.25.25","article-title":"Increased intestinal folate absorption in experimental diabetes","volume":"25","author":"Pote","year":"1998","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0525","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addr.2019.05.010","article-title":"Ligand density on nanoparticles: a parameter with critical impact on nanomedicine","volume":"143","author":"Alkilany","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0530","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1021\/acsnano.2c02084","article-title":"Quantification of available ligand density on the surface of targeted liposomal nanomedicines at the single-particle level","volume":"16","author":"Chen","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0535","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2018.07.006","article-title":"Receptor mediated transcytosis in biological barrier: the influence of receptor character and their ligand density on the transmembrane pathway of active-targeting nanocarriers","volume":"180","author":"Song","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0540","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800106","article-title":"Synergetic combinations of dual-targeting ligands for enhanced in vitro and in vivo tumor targeting","volume":"7","author":"Liu","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0545","article-title":"Rapid transport of germ-mimetic nanoparticles with dual conformational polyethylene glycol chains in biological tissues","volume":"6","author":"Yang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0550","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1016\/j.biomaterials.2013.02.019","article-title":"Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity","volume":"34","author":"Shahin","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0555","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1021\/jacs.6b13231","article-title":"Next generation precision-polyesters enabling optimization of ligand-receptor stoichiometry for modular drug delivery","volume":"139","author":"Ganugula","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118755","article-title":"Polyethylenimine grafted-chitosan based Gambogic acid copolymers for targeting cancer cells overexpressing transferrin receptors","volume":"277","author":"Park","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0565","doi-asserted-by":"crossref","first-page":"39048","DOI":"10.1021\/acsami.7b12809","article-title":"Zebrafish: a visual model to evaluate the biofate of transferrin receptor-targeted 7Peptide-decorated Coumarin 6 micelles","volume":"9","author":"Li","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0570","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41586-020-2569-1","article-title":"Structural basis of GPBAR activation and bile acid recognition","volume":"587","author":"Yang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0575","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1021\/jm701255b","article-title":"Ligand binding efficiency: trends, physical basis, and implications","volume":"51","author":"Reynolds","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0580","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.polymer.2016.11.049","article-title":"Interpolyelectrolyte complexes of lysozyme with short poly [di(carboxylatophenoxy)phosphazene]. Binding energetics and protein conformational stability","volume":"108","author":"Burova","year":"2017","journal-title":"Polymer"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0585","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13017","article-title":"The neonatal fc receptor in mucosal immune regulation","volume":"93","author":"Aaen","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2019.111337","article-title":"Ciprofloxacin-supported chitosan\/polyphosphate nanocomposite to bind bovine serum albumin: its application in drug delivery","volume":"292","author":"Manea","year":"2019","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.04.016","article-title":"Prevention of diabetes-associated fibrosis: strategies in FcRn-targeted nanosystems for oral drug delivery","volume":"175","author":"Azevedo","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0600","first-page":"299","article-title":"Neonatal fc receptor-targeted lignin-encapsulated porous silicon nanoparticles for enhanced cellular interactions and insulin permeation across the intestinal epithelium","volume":"9","author":"Martins","year":"2022","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0605","doi-asserted-by":"crossref","first-page":"16095","DOI":"10.1073\/pnas.1208857109","article-title":"Engineering neonatal fc receptor-mediated recycling and transcytosis in recombinant proteins by short terminal peptide extensions","volume":"109","author":"Sockolosky","year":"2012","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0610","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2021.11.026","article-title":"Coordination of rigidity modulation and targeting ligand modification on orally-delivered nanoparticles for the treatment of liver fibrosis","volume":"341","author":"Yu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0615","article-title":"Investigation of FcRn-mediated transepithelial mechanisms for oral nanoparticle delivery systems","volume":"4","author":"Yu","year":"2021","journal-title":"Adv. Ther. Germany"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0620","article-title":"Nanodisc-mediated conversion of virustatic antiviral antibody to disrupt virus envelope in infected cells","author":"Hwang","year":"2022","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112017","article-title":"The optimization of xanthine derivatives leading to HBK001 hydrochloride as a potent dual ligand targeting DPP-IV and GPR119","volume":"188","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117180","article-title":"Pectin co-functionalized dual layered solid lipid nanoparticle made by soluble curcumin for the targeted potential treatment of colorectal cancer","volume":"252","author":"Mohamed","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0635","doi-asserted-by":"crossref","first-page":"11380","DOI":"10.1021\/acs.langmuir.9b01168","article-title":"Riboflavin-terminated, multivalent quantum dot as fluorescent cell imaging probe","volume":"35","author":"Dalal","year":"2019","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0640","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.actbio.2020.04.005","article-title":"Hierarchically targetable fiber rods decorated with dual targeting ligands and detachable zwitterionic coronas","volume":"110","author":"Liu","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0645","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1208\/s12249-019-1325-z","article-title":"Nanoparticles: oral delivery for protein and peptide drugs","volume":"20","author":"Cao","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0650","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1039\/D0SC00518E","article-title":"Recruitment of receptors at supported lipid bilayers promoted by the multivalent binding of ligand-modified unilamellar vesicles","volume":"11","author":"Di Iorio","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0655","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2018.04.019","article-title":"The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles","volume":"279","author":"Wang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0660","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jconrel.2021.01.032","article-title":"Engineered liposomes targeting the gut\u2013CNS Axis for comprehensive therapy of spinal cord injury","volume":"331","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0665","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jconrel.2020.04.034","article-title":"Exposure of liposomes containing nanocrystallised ciprofloxacin to digestive media induces solid-state transformation and altered in vitro drug release","volume":"323","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0670","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.msec.2017.04.113","article-title":"Preparation of poly(lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin","volume":"78","author":"Xu","year":"2017","journal-title":"Mater Sci Eng C-Mater Biol Applicat"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0675","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2012.12.013","article-title":"Biocompatibility of engineered nanoparticles for drug delivery","volume":"166","author":"Naahidi","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0680","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/med.21533","article-title":"Lipidic prodrug approach for improved oral drug delivery and therapy","volume":"39","author":"Markovic","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0685","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ijpharm.2015.09.014","article-title":"Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: elucidation of mechanism of uptake using chylomicron flow blocking approach","volume":"495","author":"Makwana","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0690","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jconrel.2021.07.041","article-title":"Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates","volume":"337","author":"Tedeschini","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0695","doi-asserted-by":"crossref","DOI":"10.1063\/5.0038672","article-title":"Effects of linker flexibility on phase behavior and structure of linked colloidal gels","volume":"154","author":"Howard","year":"2021","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0700","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jcis.2019.02.048","article-title":"Impact of molecular linker size on physicochemical properties of assembled gold nanoparticle mono\u2212\/multi-layers and their applicability for functional binding of biomolecules","volume":"543","author":"Krikstolaityte","year":"2019","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0705","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/10717544.2019.1710623","article-title":"OCTN2-targeted nanoparticles for oral delivery of paclitaxel: differential impact of the polyethylene glycol linker size on drug delivery in vitro, in situ, and in vivo","volume":"27","author":"Kou","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0710","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052673","article-title":"Prodrug-based targeting approach for inflammatory bowel diseases therapy: mechanistic study of phospholipid-linker-cyclosporine PLA2-mediated activation","volume":"23","author":"Markovic","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0715","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41565-018-0171-6","article-title":"Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona","volume":"13","author":"Tonigold","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0720","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijpharm.2019.01.022","article-title":"A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems","volume":"558","author":"Sardo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0725","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801123","article-title":"Protein insulin delivery by overcoming mucus and epithelial barriers","volume":"8","author":"Wang","year":"2019","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0730","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/med.21767","article-title":"Protein corona formed in the gastrointestinal tract and its impacts on oral delivery of nanoparticles","volume":"41","author":"Zhang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0735","article-title":"Mucus penetrating and cell-binding polyzwitterionic micelles as potent oral nanomedicine for cancer drug delivery","volume":"34","author":"Wufa Fan","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0740","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1080\/10717544.2018.1480675","article-title":"Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy","volume":"25","author":"Du","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118508","article-title":"Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption","volume":"568","author":"Li","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120944","article-title":"Effective oral delivery of Exenatide-Zn2+ complex through distal ileum-targeted double layers nanocarriers modified with deoxycholic acid and glycocholic acid in diabetes therapy","volume":"275","author":"Han","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0755","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1021\/acs.molpharmaceut.8b00809","article-title":"Synthesis of CSK-DEX-PLGA nanoparticles for the oral delivery of exenatide to improve its mucus penetration and intestinal absorption","volume":"16","author":"Song","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0760","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1021\/acs.molpharmaceut.8b00357","article-title":"Entrapping of nanoparticles in yeast cell wall microparticles for macrophage-targeted oral delivery of cabazitaxel","volume":"15","author":"Ren","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0765","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.biotechadv.2014.07.006","article-title":"A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules","volume":"32","author":"Choonara","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0770","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.21037\/jgo-21-230","article-title":"Effects of molecular markers on the treatment decision and prognosis of colorectal cancer: a narrative review","volume":"12","author":"Cao","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0775","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1021\/acsnano.7b08499","article-title":"Silencing of intestinal glycoprotein CD98 by orally targeted nanoparticles enhances Chemosensitization of Colon Cancer","volume":"12","author":"Xiao","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0780","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12272-020-01219-0","article-title":"Advances in colon-targeted nano-drug delivery systems: challenges and solutions","volume":"43","author":"Naeem","year":"2020","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0785","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/j.cclet.2022.03.077","article-title":"Oral delivery of superoxide dismutase by lipid polymer hybrid nanoparticles for the treatment of ulcerative colitis","volume":"33","author":"Cui","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0790","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ymthe.2016.11.020","article-title":"Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis","volume":"25","author":"Xiao","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0795","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2174\/1567201818666210319142206","article-title":"Mannosylated solid lipid nanocarriers of chrysin to target gastric cancer: optimization and cell line study","volume":"18","author":"Pandey","year":"2021","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0800","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13071075","article-title":"Oral delivery of nucleic acids with passive and active targeting to the intestinal tissue using polymer-based nanocarriers","volume":"13","author":"Poudel","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0805","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1080\/10717544.2017.1377316","article-title":"Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB(0,+) to deliver chemotherapeutic agents for colon cancer therapy","volume":"24","author":"Kou","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0810","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2147\/IJN.S302238","article-title":"Wheat germ agglutinin-conjugated disulfide cross-linked alginate nanoparticles as a docetaxel carrier for colon cancer therapy","volume":"16","author":"Chiu","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121440","article-title":"Targeted therapeutic effects of oral inulin-modified double-layered nanoparticles containing chemotherapeutics on orthotopic colon cancer","volume":"283","author":"Hou","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0820","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ecco-jcc\/jjz113","article-title":"Oral targeted delivery by nanoparticles enhances efficacy of an Hsp90 inhibitor by reducing systemic exposure in murine models of colitis and colitis-associated cancer","volume":"14","author":"Yang","year":"2020","journal-title":"J. Crohns & Colitis"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0825","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.702173","article-title":"Lentinan-based oral nanoparticle loaded budesonide with macrophage-targeting ability for treatment of ulcerative colitis","volume":"9","author":"Lin","year":"2021","journal-title":"Frontiers In Bioengineering and Biotechnology"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0830","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41563-019-0462-9","article-title":"Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis","volume":"19","author":"Lee","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2022.11.010_bb0835","doi-asserted-by":"crossref","first-page":"10324","DOI":"10.1021\/la8009699","article-title":"Ligand-receptor interactions between surfaces: the role of binary polymer spacers","volume":"24","author":"Longo","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2022.11.010_bb0840","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.598459","article-title":"Probing ligand-receptor interaction in living cells using force measurements with optical tweezers","volume":"8","author":"Riesenberg","year":"2020","journal-title":"Front. Bioeng. Biotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922007544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922007544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:40:52Z","timestamp":1759164052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922007544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":168,"alternative-id":["S0168365922007544"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.010","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ligand-modified nanocarriers for oral drug delivery: Challenges, rational design, and applications","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}